共 50 条
- [1] COGNITIVE FAILURE IN CANCER-PATIENTS IN CLINICAL-TRIALS[J]. LANCET, 1993, 341 (8839): : 247 - 248BRUERA, ESPACHYNSKI, KMACEACHERN, THANSON, J
- [2] PROBLEMS IN CONDUCTING CLINICAL-TRIALS IN CANCER-PATIENTS[J]. ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 124 - 124BRECKENRIDGE, A
- [3] IMPACT OF CONTROLLED CLINICAL-TRIALS ON THE TREATMENT OF CANCER-PATIENTS[J]. BIOMETRICS, 1980, 36 (01) : 189 - 189SANCHOGARNIER, HFLAMANT, R
- [4] CLINICAL-TRIALS FOR CANCER-PATIENTS - THE COMMUNITY PRACTICING PHYSICIANS PERSPECTIVE[J]. CANCER, 1990, 65 (10) : 2388 - 2390FLEMING, ID
- [5] METHODOLOGY IN CLINICAL-TRIALS OF PROPHYLAXIS AND TREATMENT OF INFECTIONS IN CANCER-PATIENTS[J]. BAILLIERES CLINICAL INFECTIOUS DISEASES, 1994, 1 (03): : 455 - 468MANDELL, LA
- [6] CLINICAL-TRIALS WITH ANTI-EMETIC AGENTS IN CANCER-PATIENTS RECEIVING CHEMOTHERAPY[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9): : S11 - S22PENTA, JSPOSTER, DSBRUNO, SMACDONALD, JS
- [7] PERCEPTIONS OF CANCER-PATIENTS AND THEIR PHYSICIANS INVOLVED IN PHASE-I CLINICAL-TRIALS[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2472 - 2472WEIDEN, PLAPPELBAUM, JW
- [8] CLINICAL-TRIALS IN PATIENTS WITH CANCER[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (18): : 1105 - 1106CARTER, SK
- [9] IMPLICATIONS OF DOSE INTENSITY FOR CANCER CLINICAL-TRIALS - INTRODUCTION[J]. SEMINARS IN ONCOLOGY, 1987, 14 (04) : 1 - 2PATER, JL